Necrotic platelets provide a procoagulant surface during thrombosis

Blood

Volumn 126, Issue 26, 2015, Pages 2852-2862

  Hua, Vu Minh ^a   Abeynaike, Latasha ^a   Glaros, Elias ^a   Campbell, Heather ^a   Pasalic, Leonardo ^b   Hogg, Philip J ^c,d,g   Chen, Vivien M Y ^a,e,f  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Institute of Clinical Pathology and Medical Research   (Australia)

^c CENTENARY INSTITUTE   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e ANZAC Research Institute   (Australia)

^f ANZAC RESEARCH INSTITUTE   (Australia)

^g The Chris O Brien Lifehouse   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 [N (S GLUTATHIONYLACETYL)AMINO]PHENYLARSONOUS ACID; ACETIC ACID DERIVATIVE; ACETYLSALICYLIC ACID; ARSENIC ACID DERIVATIVE; CYCLOPHILIN D; DITHIOL DERIVATIVE; FERRIC CHLORIDE; FIBRIN; GLUTATHIONE DERIVATIVE; ORGANIC ANION TRANSPORTER; PADGEM PROTEIN; PROCOAGULANT; THROMBIN; UNCLASSIFIED DRUG; 4-(N-(S-GLUTATHIONYLACETYL)AMINO)PHENYLARSENOXIDE; BIOLOGICAL MARKER; CYCLOPHILIN; GLUTATHIONE; ORGANOARSENIC DERIVATIVE; PPID PROTEIN, HUMAN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; COVALENT BOND; CYCLOPHILIN D GENE; CYTOSOL; GENE; GENE DELETION; HEMOSTASIS; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOSIS; ANALOGS AND DERIVATIVES; ANIMAL; CELL CULTURE; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; METABOLISM; NECROSIS; PHYSIOLOGY;

ANIMALS; ARSENICALS; BIOMARKERS; BLOOD PLATELETS; CELLS, CULTURED; CYCLOPHILINS; FLOW CYTOMETRY; GLUTATHIONE; HUMANS; MICE; MICROSCOPY, CONFOCAL; NECROSIS; PLATELET ACTIVATION; THROMBOSIS;

EID: 84954530893     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-08-663005     Document Type: Article

References (45)

1. Heemskerk JW, Mattheij NJ, Cosemans JM. Platelet-based coagulation: different populations, different functions. J Thromb Haemost. 2013; 11(1):2-16.
2. Jackson SP. Arterial thrombosis-insidious, unpredictable and deadly. Nat Med. 2011;17(11): 1423-1436.
3. Butenas S, van't Veer C, Mann KG. "Normal" thrombin generation. Blood. 1999;94(7): 2169-2178.
4. Kempton CL, Hoffman M, Roberts HR, Monroe DM. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations. Arterioscler Thromb Vasc Biol. 2005;25(4):861-866.
5. London FS, Marcinkiewicz M, Walsh PN. A subpopulation of platelets responds to thrombin- or SFLLRN-stimulation with binding sites for factor IXa. J Biol Chem. 2004;279(19): 19854-19859.
6. Prodan CI, Stoner JA, Cowan LD, Dale GL. Higher coated-platelet levels are associated with stroke recurrence following nonlacunar brain infarction. J Cereb Blood Flow Metab. 2013;33(2): 287-292.
7. Schoenwaelder SM, Yuan Y, Josefsson EC, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood. 2009;114(3):663-666.
8. Jobe SM, Wilson KM, Leo L, et al. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood. 2008;111(3):1257-1265.
9. Mattheij NJ, Gilio K, van Kruchten R, et al. Dual mechanism of integrin aIIbb3 closure in procoagulant platelets. J Biol Chem. 2013; 288(19):13325-13336.
10. Bouchard BA, Paradis AK, Brummel-Ziedins KE. Measurement of procoagulant platelet subpopulations in whole blood: development of an assay for population-based studies. Thromb Res. 2011;127(1):62-64.
11. Gyulkhandanyan AV, Mutlu A, Freedman J, Leytin V. Markers of platelet apoptosis: methodology and applications. J Thromb Thrombolysis. 2012;33(4): 397-411.
12. Jackson SP, Schoenwaelder SM. Procoagulant platelets: are they necrotic? Blood. 2010;116(12): 2011-2018.
13. Kuijpers MJ, Munnix IC, Cosemans JM, et al. Key role of platelet procoagulant activity in tissue factor- and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition. Microcirculation. 2008;15(4):269-282.
14. Shi J, Pipe SW, Rasmussen JT, Heegaard CW, Gilbert GE. Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure. J Thromb Haemost. 2008;6(7):1167-1174.
15. Park D, Don AS, Massamiri T, et al. Noninvasive imaging of cell death using an Hsp90 ligand. J Am Chem Soc. 2011;133(9):2832-2835.
16. Park D, Xie BW, Van Beek ER, et al. Optical imaging of treatment-related tumor cell death using a heat shock protein-90 alkylator. Mol Pharm. 2013;10(10):3882-3891.
17. Xie BW, Park D, Van Beek ER, et al. Optical imaging of cell death in traumatic brain injury using a heat shock protein-90 alkylator. Cell Death Dis. 2013;4:e473.
18. Don AS, Kisker O, Dilda P, et al. A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells. Cancer Cell. 2003; 3(5):497-509.
19. Bevers EM, Comfurius P, van Rijn JL, Hemker HC, Zwaal RF. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem. 1982;122(2):429-436.
20. Fager AM, Wood JP, Bouchard BA, Feng P, Tracy PB. Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase. Arterioscler Thromb Vasc Biol. 2010;30(12): 2400-2407.
21. Dilda PJ, Decollogne S, Weerakoon L, et al. Optimization of the antitumor efficacy of a synthetic mitochondrial toxin by increasing the residence time in the cytosol. J Med Chem. 2009;52(20):6209-6216.
22. Dilda PJ, Ramsay EE, Corti A, Pompella A, Hogg PJ. Metabolism of the tumor angiogenesis inhibitor 4-(N-(S-Glutathionylacetyl)amino) phenylarsonous acid. J Biol Chem. 2008;283(51): 35428-35434.
23. Hagenbuch B, Meier PJ. The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta. 2003;1609(1):1-18.
24. Niessen J, Jedlitschky G, Grube M, et al. Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin. Drug Metab Dispos. 2009;37(5): 1129-1137.
25. Kobayashi D, Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I. Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J Pharmacol Exp Ther. 2003;306(2): 703-708.
26. Nakagawa T, Shimizu S, Watanabe T, et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature. 2005; 434(7033):652-658.
27. McCormack JG, Halestrap AP, Denton RM. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev. 1990;70(2):391-425.
28. Falati S, Gross P, Merrill-Skoloff G, Furie BC, Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med. 2002;8(10): 1175-1181.
29. Dubois C, Panicot-Dubois L, Gainor JF, Furie BC, Furie B. Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model. J Clin Invest. 2007;117(4):953-960.
30. Dubois C, Panicot-Dubois L, Merrill-Skoloff G, Furie B, Furie BC. Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. Blood. 2006;107(10):3902-3906.
31. Voronov RS, Stalker TJ, Brass LF, Diamond SL. Simulation of intrathrombus fluid and solute transport using in vivo clot structures with single platelet resolution. Ann Biomed Eng. 2013;41(6): 1297-1307.
32. Stalker TJ, Traxler EA, Wu J, et al. Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood. 2013;121(10):1875-1885.
33. Dale GL, Friese P, Batar P, et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature. 2002;415(6868):175-179.
34. Abaeva AA, Canault M, Kotova YN, et al. Procoagulant platelets form an α-granule proteincovered "cap" on their surface that promotes their attachment to aggregates. J Biol Chem. 2013; 288(41):29621-29632.
35. Bratosin D, Mitrofan L, Palii C, Estaquier J, Montreuil J. Novel fluorescence assay using calcein-AM for the determination of human erythrocyte viability and aging. Cytometry A. 2005;66(1):78-84.
36. Dale GL. Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemost. 2005;3(10):2185-2192.
37. Munnix IC, Kuijpers MJ, Auger J, et al. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation. Arterioscler Thromb Vasc Biol. 2007;27(11):2484-2490.
38. Schoenwaelder SM, Jarman KE, Gardiner EE, et al. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. Blood. 2011; 118(6):1663-1674.
39. Remenyi G, Szasz R, Friese P, Dale GL. Role of mitochondrial permeability transition pore in coated-platelet formation. Arterioscler Thromb Vasc Biol. 2005;25(2):467-471.
40. Liu F, Gamez G, Myers DR, Clemmons W, Lam WA, Jobe SM. Mitochondrially mediated integrin aIIbb3 protein inactivation limits thrombus growth. J Biol Chem. 2013;288(42):30672-30681.
41. Ivanciu L, Krishnaswamy S, Camire RM. New insights into the spatiotemporal localization of prothrombinase in vivo. Blood. 2014;124(11): 1705-1714.
42. Vandendries ER, Hamilton JR, Coughlin SR, Furie B, Furie BC. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis. Proc Natl Acad Sci USA. 2007;104(1):288-292.
43. Prodan CI, Joseph PM, Vincent AS, Dale GL. Coated-platelet levels are influenced by smoking, aspirin, and selective serotonin reuptake inhibitors. J Thromb Haemost. 2007;5(10): 2149-2151.
44. Norgard NB, Saya S, Hann CL, Hennebry TA, Schechter E, Dale GL. Clopidogrel attenuates coated-platelet production in patients undergoing elective coronary catheterization. J Cardiovasc Pharmacol. 2008;52(6): 536-539.
45. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329): 71-86.